SERUM BILIRUBIN AND ANTIOXIDANT LEVELS IN FIRST DEGREE RELATIVES OF PATIENTS WITH ISCHEMIC HEART DISEASE AND NORMAL SUBJECTS
Abstract
Background: Coronary diseases appear to result from an overbalance between radical-generating,compared with radical-scavenging systems, a condition called as oxidative stress. Total antioxidant status
(TAS) in human plasma reflects the balance between oxidants and antioxidants in each system. Bilirubin
has been considered an antioxidant, with capacity to remove reactive species of oxygen. Present study
tried to measure the total antioxidant status of first degree relatives of patients with IHD. Study also tried
to evaluate the prognostic role of serum bilirubin in disease prevention or progression. Methods: Seventy
five apparently healthy subjects in age group 20-50 years, comprising equal number of males and
females, who were first degree relatives of ischemic heart disease patients, were included in the study.
Family members were divided on the bases of their numbers, i.e., one family member (Group-A), 2 family
members (Group-B) and more than 3 family members (Group-C). Study was cross sectional and carried
out in a period of 6 months (Jun 2008-Jan 2009). Subjects with letter of consent were taken from general
population. Seventy five healthy age matched people with no history of ischemic heart disease in family
were taken as control. An overnight fasting blood sample was taken. Total antioxidant status was
determined using a commercially available kit. Serum bilirubin was estimated by auto analyzer. Results:
Family history of ischemic heart disease with serum bilirubin showed a significant negative correlation
(p<0.05). But the values of TAS failed to show any significant correlation with the family history. It was
observed that the value of serum bilirubin was decreased significantly (p<0.05) with an increased number
of family members. Total antioxidant status failed to show any significant difference among all the three
groups. Conclusion: Our data demonstrated that reduced serum levels of bilirubin were seen in people
with a higher prevalence of coronary artery disease in the family. The levels of serum bilirubin showed a
downward trend with an increase in number of family members affected with ischemic heart disease.
Present study failed to show a definite association of total antioxidant status with family history of
ischemic heart disease. Additional studies are still necessary on large number of first degree relatives to
confirm and demonstrate the association of these findings with clinical outcomes.
Keywords: Ischemic heart disease, first degree relatives, total antioxidant status and bilirubin
References
Paffenbarger RS Jr, Hyde RT, Wing AL, Lee IM, Jung DL,
Kampert JB. The association of changes in physical-activity level
and other lifestyle characteristics with mortality among men. N
Engl J Med 1993;328:538-45.
Stewart MW, Humphriss DB, Mitcheson J, Webster J, Walker M,
Laker MF. Lipoprotein composition and serum apolipoproteins in
normoglycaemic first degree relations of non insulin dependent
diabetic patients. Atherosclerosis 1998;139:115-21.
Fukagawa NK. Aging: is oxidative stress a marker or is it causal?
Proc Soc Exp Biol Med 1999;222:293-8.
Harrison DG. Endothelial function and oxidant stress. Clin
Cardiol 1997;20(11 Supp 2):II-11-7.
Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA,
Ahmad M, et al. Vascular cell adhesion molecule-1 (VCAM-1)
gene transcription and expression are regulated through an
antioxidant-sensitive mechanism in human vascular endothelial
cells. J Clin Invest 1993;92:1866-74.
Alho H, Leinonen J. Total antioxidant activity measured by
chemiluminescence methods. Methods Enzymol 1999;299:3-15.
Trapani L, Segatto M, Incerpi S, Pallottini V. 3-Hydroxy 3-
Methylglutaryl Coenzyme A Reductase Regulation by
Antioxidant Compounds: New Therapeutic Tools for
Hypercholesterolemia? Curr Mol Med 2011;11:790-7.
Wang XL, Rainwater DL, Vande Berg JF, Mitchell BD, Mahaney
MC. Genetic contribution to plasma antioxidant activity.
Arterioscler Thromb Vasc Biol 2001;21:1190-5.
Wei S, Gao C, Wei G, Chen Y, Zhong L, Li X. The level of
serum bilirubin associated with coronary lesion types in patients
with coronary artery disease. J Cardiovasc Med (Hagerstown)
;27: [Epub ahead of print]
Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes
controlling bilirubin concentrations as biomarkers for
cardiovascular disease. Clin Chem 2010;56:1535-43.
Kuwano T, Miura S, Shirai K, Ike A, Mori K, Shimizu T, et al.
Serum levels of bilirubin as an independent predictor of coronary
in-stentrestenosis: a new look at an old molecule. J Atheroscler
Thromb 2011;18:574-83.
Yoshino S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A,
Oketani N, et al. Relationship between bilirubin concentration,
coronary endothelial function, and inflammatory stress in
overweight patients. J Atheroscler Thromb 2011;18:403-12.
Huang SS, Huang PH, Leu HB, Wu TC, Lin SJ, Chen JW. Serum
bilirubin predicts long-term clinical outcomes in patients with
cardiac syndrome X. Heart 2010;96:1227-32.
Ghem C, Sarmento-Leite RE, de Quadros AS, Rossetto S,
Gottschall CA. Serum bilirubin concentration in patients with an
established coronary artery disease. Int Heart J 2010;51(2):86-91.
Gul R, Anjum T, Yasmin R, Ijaz RM, Saleem M. Serum total
antioxidant status in cardiovascular patients and in healthy
individuals. Pak J Biochem Mol Biol 2010;43(3):140-3.
Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Effect
of serum albumin and bilirubin on the risk of myocardial
infarction (the Framingham Offspring Study). Am J Cardiol
;91:485-8.
Djousse L, Levy D, Cupples LA, Evans JC, D' Agostino RB,
Ellison RC. Total serum bilirubin and risk of cardiovascular
disease in the Framingham offspring study. Am J Cardiol
;87:1196-200.
Madhavan M, Wattigney WA, Srinivasan SR, Berenson GS.
Serum bilirubin distribution and its relation to cardiovascular risk
in children and young adults. Atherosclerosis 1997;131:107-13.
Halliwell B, Gutteridge JMC. Free Radicals in Biology and
Medicine. 3rd ed. Oxford UK: Oxford University Press; 1999.
Wang X, Yu Y, Ji L, Liang X, Zhang T, Hai CX. Alpha-lipoic
acid protects against myocardial ischemia/reperfusion injury via
multiple target effects. Food Chem Toxicol 2011;49:2750-7.
Olisekodiaka MJ, Igbeneghu CA, Onuegbu AJ, Oduru R, Lawal
AO. Lipid, Lipoproteins, Total Antioxidant Status and Organ
Changes in Rats Administered High Doses of Cadmium Chloride.
Med Princ Pract 2011. [Epub ahead of print]
Gururajan P, Gurumurthy P, Nayar P, Chockalingam M,
Bhuvaneshwari S, Babu S, et al. Lipid profile and non-enzymic
antioxidant status in patients with acute coronary syndrome in
South India. Heart Lung Circ 2010;19(2):75-80.
Higgins M. Epidemiology and prevention of coronary heart
disease in families. Am J Med 2000;108:387-95.
Centers for Disease Control (CDC). The Surgeon General's
Report on Reducing the Health Consequences of
Smoking: 25 Years of Progress. MMWR Morb Mortal Wkly
Rep 1989;38(Suppl 2):1-32.
Potter AS, Foroudi S, Stamatikos A, Patil BS, Deyhim F.
Drinking carrot juice increases total antioxidant status and
decreases lipid peroxidation in adults. Nutr J 2011;10:96.
Downloads
Published
How to Cite
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
